Table of Content

1 VAT1 Antibody Market Overview
1.1 VAT1 Antibody Product Overview
1.2 VAT1 Antibody Market Segment by Type
1.2.1 Monoclonal
1.2.2 Polyclonal
1.3 Global VAT1 Antibody Market Size by Type
1.3.1 Global VAT1 Antibody Market Size Overview by Type (2018-2033)
1.3.2 Global VAT1 Antibody Historic Market Size Review by Type (2018-2023)
1.3.3 Global VAT1 Antibody Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America VAT1 Antibody Sales Breakdown by Type (2018-2023)
1.4.2 Europe VAT1 Antibody Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific VAT1 Antibody Sales Breakdown by Type (2018-2023)
1.4.4 Latin America VAT1 Antibody Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa VAT1 Antibody Sales Breakdown by Type (2018-2023)
2 Global VAT1 Antibody Market Competition by Company
2.1 Global Top Players by VAT1 Antibody Sales (2018-2023)
2.2 Global Top Players by VAT1 Antibody Revenue (2018-2023)
2.3 Global Top Players by VAT1 Antibody Price (2018-2023)
2.4 Global Top Manufacturers VAT1 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 VAT1 Antibody Market Competitive Situation and Trends
2.5.1 VAT1 Antibody Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by VAT1 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in VAT1 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into VAT1 Antibody Market
2.8 Key Manufacturers VAT1 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 VAT1 Antibody Status and Outlook by Region
3.1 Global VAT1 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global VAT1 Antibody Historic Market Size by Region
3.2.1 Global VAT1 Antibody Sales in Volume by Region (2018-2023)
3.2.2 Global VAT1 Antibody Sales in Value by Region (2018-2023)
3.2.3 Global VAT1 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global VAT1 Antibody Forecasted Market Size by Region
3.3.1 Global VAT1 Antibody Sales in Volume by Region (2024-2033)
3.3.2 Global VAT1 Antibody Sales in Value by Region (2024-2033)
3.3.3 Global VAT1 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global VAT1 Antibody by Application
4.1 VAT1 Antibody Market Segment by Application
4.1.1 Immunochemistry (IHC)
4.1.2 Immunofluorescence (IF)
4.1.3 Immunoprecipitation (IP)
4.1.4 Western Blot (WB)
4.1.5 ELISA
4.1.6 Others
4.2 Global VAT1 Antibody Market Size by Application
4.2.1 Global VAT1 Antibody Market Size Overview by Application (2018-2033)
4.2.2 Global VAT1 Antibody Historic Market Size Review by Application (2018-2023)
4.2.3 Global VAT1 Antibody Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America VAT1 Antibody Sales Breakdown by Application (2018-2023)
4.3.2 Europe VAT1 Antibody Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific VAT1 Antibody Sales Breakdown by Application (2018-2023)
4.3.4 Latin America VAT1 Antibody Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa VAT1 Antibody Sales Breakdown by Application (2018-2023)
5 North America VAT1 Antibody by Country
5.1 North America VAT1 Antibody Historic Market Size by Country
5.1.1 North America VAT1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America VAT1 Antibody Sales in Volume by Country (2018-2023)
5.1.3 North America VAT1 Antibody Sales in Value by Country (2018-2023)
5.2 North America VAT1 Antibody Forecasted Market Size by Country
5.2.1 North America VAT1 Antibody Sales in Volume by Country (2024-2033)
5.2.2 North America VAT1 Antibody Sales in Value by Country (2024-2033)
6 Europe VAT1 Antibody by Country
6.1 Europe VAT1 Antibody Historic Market Size by Country
6.1.1 Europe VAT1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe VAT1 Antibody Sales in Volume by Country (2018-2023)
6.1.3 Europe VAT1 Antibody Sales in Value by Country (2018-2023)
6.2 Europe VAT1 Antibody Forecasted Market Size by Country
6.2.1 Europe VAT1 Antibody Sales in Volume by Country (2024-2033)
6.2.2 Europe VAT1 Antibody Sales in Value by Country (2024-2033)
7 Asia-Pacific VAT1 Antibody by Region
7.1 Asia-Pacific VAT1 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific VAT1 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific VAT1 Antibody Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific VAT1 Antibody Sales in Value by Region (2018-2023)
7.2 Asia-Pacific VAT1 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific VAT1 Antibody Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific VAT1 Antibody Sales in Value by Region (2024-2033)
8 Latin America VAT1 Antibody by Country
8.1 Latin America VAT1 Antibody Historic Market Size by Country
8.1.1 Latin America VAT1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America VAT1 Antibody Sales in Volume by Country (2018-2023)
8.1.3 Latin America VAT1 Antibody Sales in Value by Country (2018-2023)
8.2 Latin America VAT1 Antibody Forecasted Market Size by Country
8.2.1 Latin America VAT1 Antibody Sales in Volume by Country (2024-2033)
8.2.2 Latin America VAT1 Antibody Sales in Value by Country (2024-2033)
9 Middle East and Africa VAT1 Antibody by Country
9.1 Middle East and Africa VAT1 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa VAT1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa VAT1 Antibody Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa VAT1 Antibody Sales in Value by Country (2018-2023)
9.2 Middle East and Africa VAT1 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa VAT1 Antibody Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa VAT1 Antibody Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Company Information
10.1.2 Thermo Fisher Scientific Introduction and Business Overview
10.1.3 Thermo Fisher Scientific VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific VAT1 Antibody Products Offered
10.1.5 Thermo Fisher Scientific Recent Development
10.2 ProSci
10.2.1 ProSci Company Information
10.2.2 ProSci Introduction and Business Overview
10.2.3 ProSci VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ProSci VAT1 Antibody Products Offered
10.2.5 ProSci Recent Development
10.3 Bioss
10.3.1 Bioss Company Information
10.3.2 Bioss Introduction and Business Overview
10.3.3 Bioss VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bioss VAT1 Antibody Products Offered
10.3.5 Bioss Recent Development
10.4 Bethyl Laboratories
10.4.1 Bethyl Laboratories Company Information
10.4.2 Bethyl Laboratories Introduction and Business Overview
10.4.3 Bethyl Laboratories VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bethyl Laboratories VAT1 Antibody Products Offered
10.4.5 Bethyl Laboratories Recent Development
10.5 LifeSpan BioSciences
10.5.1 LifeSpan BioSciences Company Information
10.5.2 LifeSpan BioSciences Introduction and Business Overview
10.5.3 LifeSpan BioSciences VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.5.4 LifeSpan BioSciences VAT1 Antibody Products Offered
10.5.5 LifeSpan BioSciences Recent Development
10.6 Abcam
10.6.1 Abcam Company Information
10.6.2 Abcam Introduction and Business Overview
10.6.3 Abcam VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abcam VAT1 Antibody Products Offered
10.6.5 Abcam Recent Development
10.7 Novus Biologicals
10.7.1 Novus Biologicals Company Information
10.7.2 Novus Biologicals Introduction and Business Overview
10.7.3 Novus Biologicals VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novus Biologicals VAT1 Antibody Products Offered
10.7.5 Novus Biologicals Recent Development
10.8 RayBiotech
10.8.1 RayBiotech Company Information
10.8.2 RayBiotech Introduction and Business Overview
10.8.3 RayBiotech VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.8.4 RayBiotech VAT1 Antibody Products Offered
10.8.5 RayBiotech Recent Development
10.9 EpiGentek
10.9.1 EpiGentek Company Information
10.9.2 EpiGentek Introduction and Business Overview
10.9.3 EpiGentek VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.9.4 EpiGentek VAT1 Antibody Products Offered
10.9.5 EpiGentek Recent Development
10.10 OriGene Technologies
10.10.1 OriGene Technologies Company Information
10.10.2 OriGene Technologies Introduction and Business Overview
10.10.3 OriGene Technologies VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.10.4 OriGene Technologies VAT1 Antibody Products Offered
10.10.5 OriGene Technologies Recent Development
10.11 ABclonal Technology
10.11.1 ABclonal Technology Company Information
10.11.2 ABclonal Technology Introduction and Business Overview
10.11.3 ABclonal Technology VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.11.4 ABclonal Technology VAT1 Antibody Products Offered
10.11.5 ABclonal Technology Recent Development
10.12 Santa Cruz Biotechnology
10.12.1 Santa Cruz Biotechnology Company Information
10.12.2 Santa Cruz Biotechnology Introduction and Business Overview
10.12.3 Santa Cruz Biotechnology VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Santa Cruz Biotechnology VAT1 Antibody Products Offered
10.12.5 Santa Cruz Biotechnology Recent Development
10.13 BosterBio
10.13.1 BosterBio Company Information
10.13.2 BosterBio Introduction and Business Overview
10.13.3 BosterBio VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.13.4 BosterBio VAT1 Antibody Products Offered
10.13.5 BosterBio Recent Development
10.14 Proteintech Group
10.14.1 Proteintech Group Company Information
10.14.2 Proteintech Group Introduction and Business Overview
10.14.3 Proteintech Group VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Proteintech Group VAT1 Antibody Products Offered
10.14.5 Proteintech Group Recent Development
10.15 Aviva Systems Biology
10.15.1 Aviva Systems Biology Company Information
10.15.2 Aviva Systems Biology Introduction and Business Overview
10.15.3 Aviva Systems Biology VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Aviva Systems Biology VAT1 Antibody Products Offered
10.15.5 Aviva Systems Biology Recent Development
10.16 United States Biological
10.16.1 United States Biological Company Information
10.16.2 United States Biological Introduction and Business Overview
10.16.3 United States Biological VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.16.4 United States Biological VAT1 Antibody Products Offered
10.16.5 United States Biological Recent Development
10.17 Biobyt
10.17.1 Biobyt Company Information
10.17.2 Biobyt Introduction and Business Overview
10.17.3 Biobyt VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Biobyt VAT1 Antibody Products Offered
10.17.5 Biobyt Recent Development
10.18 Jingjie PTM BioLab
10.18.1 Jingjie PTM BioLab Company Information
10.18.2 Jingjie PTM BioLab Introduction and Business Overview
10.18.3 Jingjie PTM BioLab VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Jingjie PTM BioLab VAT1 Antibody Products Offered
10.18.5 Jingjie PTM BioLab Recent Development
10.19 Beijing Solarbio
10.19.1 Beijing Solarbio Company Information
10.19.2 Beijing Solarbio Introduction and Business Overview
10.19.3 Beijing Solarbio VAT1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Beijing Solarbio VAT1 Antibody Products Offered
10.19.5 Beijing Solarbio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 VAT1 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 VAT1 Antibody Industrial Chain Analysis
11.4 VAT1 Antibody Market Dynamics
11.4.1 VAT1 Antibody Industry Trends
11.4.2 VAT1 Antibody Market Drivers
11.4.3 VAT1 Antibody Market Challenges
11.4.4 VAT1 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 VAT1 Antibody Distributors
12.3 VAT1 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal
Table 2. Major Company of Polyclonal
Table 3. Global VAT1 Antibody Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global VAT1 Antibody Sales by Type (2018-2023) & (ml)
Table 5. Global VAT1 Antibody Sales Market Share in Volume by Type (2018-2023)
Table 6. Global VAT1 Antibody Sales by Type (2018-2023) & (US& Million)
Table 7. Global VAT1 Antibody Market Share in Value by Type (2018-2023)
Table 8. Global VAT1 Antibody Price by Type (2018-2023) & (US$/ml)
Table 9. Global VAT1 Antibody Sales by Type (2024-2033) & (ml)
Table 10. Global VAT1 Antibody Sales Market Share in Volume by Type (2024-2033)
Table 11. Global VAT1 Antibody Sales by Type (2024-2033) & (US$ Million)
Table 12. Global VAT1 Antibody Sales Market Share in Value by Type (2024-2033)
Table 13. Global VAT1 Antibody Price by Type (2024-2033) & (US$/ml)
Table 14. North America VAT1 Antibody Sales by Type (2018-2023) & (ml)
Table 15. North America VAT1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe VAT1 Antibody Sales (ml) by Type (2018-2023)
Table 17. Europe VAT1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific VAT1 Antibody Sales (ml) by Type (2018-2023)
Table 19. Asia-Pacific VAT1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America VAT1 Antibody Sales (ml) by Type (2018-2023)
Table 21. Latin America VAT1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa VAT1 Antibody Sales (ml) by Type (2018-2023)
Table 23. Middle East and Africa VAT1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 24. Global VAT1 Antibody Sales by Company (2018-2023) & (ml)
Table 25. Global VAT1 Antibody Sales Share by Company (2018-2023)
Table 26. Global VAT1 Antibody Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global VAT1 Antibody Revenue Share by Company (2018-2023)
Table 28. Global Market VAT1 Antibody Price by Company (2018-2023) & (US$/ml)
Table 29. Global VAT1 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global VAT1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in VAT1 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into VAT1 Antibody Market
Table 33. Key Manufacturers VAT1 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global VAT1 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global VAT1 Antibody Sales by Region (2018-2023) & (ml)
Table 37. Global VAT1 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 38. Global VAT1 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 39. Global VAT1 Antibody Sales Market Share in Value by Region (2018-2023)
Table 40. Global VAT1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 41. Global VAT1 Antibody Sales by Region (2024-2033) & (ml)
Table 42. Global VAT1 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 43. Global VAT1 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 44. Global VAT1 Antibody Sales Market Share in Value by Region (2024-2033)
Table 45. Global VAT1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2024-2033)
Table 46. Global VAT1 Antibody Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global VAT1 Antibody Sales by Application (2018-2023) & (ml)
Table 48. Global VAT1 Antibody Sales Market Share in Volume by Application (2018-2023)
Table 49. Global VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 50. Global VAT1 Antibody Sales Market Share in Value by Application (2018-2023)
Table 51. Global VAT1 Antibody Price by Application (2018-2023) & (US$/ml)
Table 52. Global VAT1 Antibody Sales by Application (2024-2033) & (ml)
Table 53. Global VAT1 Antibody Sales Market Share in Volume by Application (2024-2033)
Table 54. Global VAT1 Antibody Sales by Application (2024-2033) & (US$ Million)
Table 55. Global VAT1 Antibody Sales Market Share in Value by Application (2024-2033)
Table 56. Global VAT1 Antibody Price by Application (2024-2033) & (US$/ml)
Table 57. North America VAT1 Antibody Sales by Application (2018-2023) (ml)
Table 58. North America VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe VAT1 Antibody Sales by Application (2018-2023) (ml)
Table 60. Europe VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific VAT1 Antibody Sales by Application (2018-2023) (ml)
Table 62. Asia-Pacific VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America VAT1 Antibody Sales by Application (2018-2023) (ml)
Table 64. Latin America VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa VAT1 Antibody Sales by Application (2018-2023) (ml)
Table 66. Middle East and Africa VAT1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 67. North America VAT1 Antibody Sales by Country (2018-2023) & (ml)
Table 68. North America VAT1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 69. North America VAT1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 70. North America VAT1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 71. North America VAT1 Antibody Sales by Country (2024-2033) & (ml)
Table 72. North America VAT1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 73. North America VAT1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 74. North America VAT1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 75. Europe VAT1 Antibody Sales by Country (2018-2023) & (ml)
Table 76. Europe VAT1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe VAT1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe VAT1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 79. Europe VAT1 Antibody Sales by Country (2024-2033) & (ml)
Table 80. Europe VAT1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe VAT1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe VAT1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific VAT1 Antibody Sales by Region (2018-2023) & (ml)
Table 84. Asia-Pacific VAT1 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific VAT1 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific VAT1 Antibody Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific VAT1 Antibody Sales by Region (2024-2033) & (ml)
Table 88. Asia-Pacific VAT1 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific VAT1 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific VAT1 Antibody Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America VAT1 Antibody Sales by Country (2018-2023) & (ml)
Table 92. Latin America VAT1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America VAT1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America VAT1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America VAT1 Antibody Sales by Country (2024-2033) & (ml)
Table 96. Latin America VAT1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America VAT1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America VAT1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa VAT1 Antibody Sales by Country (2018-2023) & (ml)
Table 100. Middle East and Africa VAT1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa VAT1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa VAT1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa VAT1 Antibody Sales by Country (2024-2033) & (ml)
Table 104. Middle East and Africa VAT1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa VAT1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa VAT1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 107. Thermo Fisher Scientific Company Information
Table 108. Thermo Fisher Scientific Introduction and Business Overview
Table 109. Thermo Fisher Scientific VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 110. Thermo Fisher Scientific VAT1 Antibody Product
Table 111. Thermo Fisher Scientific Recent Development
Table 112. ProSci Company Information
Table 113. ProSci Introduction and Business Overview
Table 114. ProSci VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 115. ProSci VAT1 Antibody Product
Table 116. ProSci Recent Development
Table 117. Bioss Company Information
Table 118. Bioss Introduction and Business Overview
Table 119. Bioss VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 120. Bioss VAT1 Antibody Product
Table 121. Bioss Recent Development
Table 122. Bethyl Laboratories Company Information
Table 123. Bethyl Laboratories Introduction and Business Overview
Table 124. Bethyl Laboratories VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 125. Bethyl Laboratories VAT1 Antibody Product
Table 126. Bethyl Laboratories Recent Development
Table 127. LifeSpan BioSciences Company Information
Table 128. LifeSpan BioSciences Introduction and Business Overview
Table 129. LifeSpan BioSciences VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 130. LifeSpan BioSciences VAT1 Antibody Product
Table 131. LifeSpan BioSciences Recent Development
Table 132. Abcam Company Information
Table 133. Abcam Introduction and Business Overview
Table 134. Abcam VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 135. Abcam VAT1 Antibody Product
Table 136. Abcam Recent Development
Table 137. Novus Biologicals Company Information
Table 138. Novus Biologicals Introduction and Business Overview
Table 139. Novus Biologicals VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 140. Novus Biologicals VAT1 Antibody Product
Table 141. Novus Biologicals Recent Development
Table 142. RayBiotech Company Information
Table 143. RayBiotech Introduction and Business Overview
Table 144. RayBiotech VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 145. RayBiotech VAT1 Antibody Product
Table 146. RayBiotech Recent Development
Table 147. EpiGentek Company Information
Table 148. EpiGentek Introduction and Business Overview
Table 149. EpiGentek VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 150. EpiGentek VAT1 Antibody Product
Table 151. EpiGentek Recent Development
Table 152. OriGene Technologies Company Information
Table 153. OriGene Technologies Introduction and Business Overview
Table 154. OriGene Technologies VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 155. OriGene Technologies VAT1 Antibody Product
Table 156. OriGene Technologies Recent Development
Table 157. ABclonal Technology Company Information
Table 158. ABclonal Technology Introduction and Business Overview
Table 159. ABclonal Technology VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 160. ABclonal Technology VAT1 Antibody Product
Table 161. ABclonal Technology Recent Development
Table 162. Santa Cruz Biotechnology Company Information
Table 163. Santa Cruz Biotechnology Introduction and Business Overview
Table 164. Santa Cruz Biotechnology VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 165. Santa Cruz Biotechnology VAT1 Antibody Product
Table 166. Santa Cruz Biotechnology Recent Development
Table 167. BosterBio Company Information
Table 168. BosterBio Introduction and Business Overview
Table 169. BosterBio VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 170. BosterBio VAT1 Antibody Product
Table 171. BosterBio Recent Development
Table 172. Proteintech Group Company Information
Table 173. Proteintech Group Introduction and Business Overview
Table 174. Proteintech Group VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 175. Proteintech Group VAT1 Antibody Product
Table 176. Proteintech Group Recent Development
Table 177. Aviva Systems Biology Company Information
Table 178. Aviva Systems Biology Introduction and Business Overview
Table 179. Aviva Systems Biology VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 180. Aviva Systems Biology VAT1 Antibody Product
Table 181. Aviva Systems Biology Recent Development
Table 182. United States Biological Company Information
Table 183. United States Biological Introduction and Business Overview
Table 184. United States Biological VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 185. United States Biological VAT1 Antibody Product
Table 186. United States Biological Recent Development
Table 187. Biobyt Company Information
Table 188. Biobyt Introduction and Business Overview
Table 189. Biobyt VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 190. Biobyt VAT1 Antibody Product
Table 191. Biobyt Recent Development
Table 192. Jingjie PTM BioLab Company Information
Table 193. Jingjie PTM BioLab Introduction and Business Overview
Table 194. Jingjie PTM BioLab VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 195. Jingjie PTM BioLab VAT1 Antibody Product
Table 196. Jingjie PTM BioLab Recent Development
Table 197. Beijing Solarbio Company Information
Table 198. Beijing Solarbio Introduction and Business Overview
Table 199. Beijing Solarbio VAT1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 200. Beijing Solarbio VAT1 Antibody Product
Table 201. Beijing Solarbio Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. VAT1 Antibody Market Trends
Table 205. VAT1 Antibody Market Drivers
Table 206. VAT1 Antibody Market Challenges
Table 207. VAT1 Antibody Market Restraints
Table 208. VAT1 Antibody Distributors List
Table 209. VAT1 Antibody Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. VAT1 Antibody Product Picture
Figure 2. Global VAT1 Antibody Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global VAT1 Antibody Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global VAT1 Antibody Sales Status and Outlook (2018-2033) & (ml)
Figure 5. Product Picture of Monoclonal
Figure 6. Global Monoclonal Sales YoY Growth (2018-2033) & (ml)
Figure 7. Product Picture of Polyclonal
Figure 8. Global Polyclonal Sales YoY Growth (2018-2033) & (ml)
Figure 9. Global VAT1 Antibody Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global VAT1 Antibody Sales Market Share by Type in 2022 & 2033
Figure 11. North America VAT1 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America VAT1 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe VAT1 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe VAT1 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific VAT1 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific VAT1 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America VAT1 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America VAT1 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa VAT1 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa VAT1 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by VAT1 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by VAT1 Antibody Revenue in 2022
Figure 23. VAT1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Immunochemistry (IHC)
Figure 25. Global Immunochemistry (IHC) Sales YoY Growth (2018-2033) & (ml)
Figure 26. Product Picture of Immunofluorescence (IF)
Figure 27. Global Immunofluorescence (IF) Sales YoY Growth (2018-2033) & (ml)
Figure 28. Product Picture of Immunoprecipitation (IP)
Figure 29. Global Immunoprecipitation (IP) Sales YoY Growth (2018-2033) & (ml)
Figure 30. Product Picture of Western Blot (WB)
Figure 31. Global Western Blot (WB) Sales YoY Growth (2018-2033) & (ml)
Figure 32. Product Picture of ELISA
Figure 33. Global ELISA Sales YoY Growth (2018-2033) & (ml)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2033) & (ml)
Figure 36. Global VAT1 Antibody Sales by Application (2018-2033) & (US$ Million)
Figure 37. Global VAT1 Antibody Sales Market Share by Application in 2022 & 2033
Figure 38. North America VAT1 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America VAT1 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe VAT1 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe VAT1 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific VAT1 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific VAT1 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America VAT1 Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America VAT1 Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa VAT1 Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. VAT1 Antibody Manufacturing Cost Structure
Figure 49. VAT1 Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed